Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2026

Go back to Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2026
ENANTA PHARM (NASDAQ: ENTA) Delayed: 11.90 +0.39 (3.39%)
Previous Close $11.51    52 Week High $34.49 
Open $11.48    52 Week Low $20.39 
Day High $12.10    P/E N/A 
Day Low $11.11    EPS $-3.18 
Volume 190,272